Imbalanced synthesis of interleukin-1beta and interleukin-1 receptor antagonist: prognostication in intestinal-type gastric cancer. 2005

C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon
D016207 Cytokines Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner. Cytokine
D017472 Receptors, Interleukin-1 Cell surface receptors that are specific for INTERLEUKIN-1. Included under this heading are signaling receptors, non-signaling receptors and accessory proteins required for receptor signaling. Signaling from interleukin-1 receptors occurs via interaction with SIGNAL TRANSDUCING ADAPTOR PROTEINS such as MYELOID DIFFERENTIATION FACTOR 88. IL-1 Receptor,IL-1 Receptors,IL1 Receptor,Interleukin-1 Receptor,Interleukin-1 Receptors,Receptor, Interleukin-1,Receptors, IL-1,IL1 Receptors,Interleukin 1 Receptor,IL 1 Receptor,IL 1 Receptors,Interleukin 1 Receptors,Receptor, IL-1,Receptor, IL1,Receptor, Interleukin 1,Receptors, IL 1,Receptors, IL1,Receptors, Interleukin 1

Related Publications

C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
September 2006, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
November 2010, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
April 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
February 2009, Pediatric neurology,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
August 2009, Clinical & experimental ophthalmology,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
December 2002, Rheumatology (Oxford, England),
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
January 2001, Scandinavian journal of rheumatology,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
August 2018, International journal of clinical oncology,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
August 2009, Circulation journal : official journal of the Japanese Circulation Society,
C Miki, and N Konishi, and E Ojima, and K Tanaka, and Y Mohri, and H Tonouchi, and M Kusunoki
May 1997, European journal of obstetrics, gynecology, and reproductive biology,
Copied contents to your clipboard!